logo
Share SHARE
FONT-SIZE Plus   Neg

GenVec Names Cynthia Collins President, CEO - Quick Facts

GenVec, Inc. (GNVC) said it appointed Cynthia Collins as president and chief executive officer, or CEO, effective May 23, 2012. Besides, Collins is expected to be appointed to the Board of Directors of GenVec.

Effective upon Collins' appointment, Paul Fischer will step down as GenVec's president and CEO and as a member of the Board.

Collins formerly served as Group vice president, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011. Before joining Beckman Coulter, she served as CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs. Before that, she served as president of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
Follow RTT